News
In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal ...
Pfizer (PFE) recently announced that the U.S. Food and Drug Administration accepted the New Drug Application for ...
This story was originally published by ProPublica, a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story ...
Pfizer's experimental drug to treat sickle cell anemia failed to meet the main goal in a late stage trial, the drugmaker said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results